Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

Rx insights using mobile technology

Harnessing the strengths of mobile research in pharma

- PMLiVE

Orphan status in US for Astellas/ Basilea antifungal

Isavuconazole is being developed as a treatment for invasive aspergillosis

- PMLiVE

FDA gives Alexion’s metabolic drug breakthrough status

Reduces requirements for registration, potentially speeding up approval

- PMLiVE

Amgen boosts Japan prospects with Astellas partnership

Companies establish joint venture and plan to co-develop new medicines

- PMLiVE

Gilead launches combination HIV pill in UK and Germany

Stribild is approved in EU as once-daily single tablet

- PMLiVE

New report points to demise of stand-alone digital agencies

85 per cent of marketing graduates believe social media and digital will integrate into full-service agencies

- PMLiVE

Sanofi hires David Loew from Roche

Will head commercial operations in Europe

- PMLiVE

Organs on demand: the future of transplants

Researchers in the US have transplanted lab-grown kidneys into animals that are functional and produce urine, though not as efficiently as the real thing

- PMLiVE

Boehringer/ Lilly launch online diabetes management game

Pharma companies aim to raise awareness of type 2 diabetes complications

- PMLiVE

AstraZeneca offers $443m to buy Omthera

Adds to list of deals to boost flagging pipeline

- PMLiVE

Bayer wins EU approval for Xarelto in ACS

Comes despite US FDA decision not to recommend extra indication for anticoagulant

- PMLiVE

Valeant buys Bausch + Lomb for $8.7bn

Biggest deal yet for acquisition-hungry Canadian pharma company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links